Market Overview

Teleflex Announces First Patient Enrollment in Clinical Study Evaluating CleanSweep™ Closed Suction System's Effects on Ventilator Mechanics Versus a Traditional Closed Suction Catheter

Share:

Teleflex Incorporated (NYSE:TFX), a leading global provider of medical
technologies for critical care and surgery, today announced the first
patient enrollment in a U.S. clinical study of CleanSweep™ Closed
Suction System at Duke University Hospital in Durham, NC.

CleanSweep Closed Suction System utilizes the dual operation of balloon
sweeping technology with traditional suction collection to remove
secretion build-up inside the endotracheal (ET) tube. In benchtop
testing, CleanSweep Closed Suction System removed 2.5 times more
secretions than the leading traditional closed suction device.
CleanSweep Closed Suction System is designed to easily integrate into
current airway management protocols, while providing enhanced secretion
removal.

"During mechanical ventilation, secretions accumulate and microbial
biofilm may form inside the ET tube. Even small reductions in ET tube
radius can increase airflow resistance significantly," said Neil
MacIntyre, M.D., professor of medicine at Duke University Hospital. "The
CleanSweep Closed Suction System may offer significant advantages in
reducing ET tube obstruction."

Selection criteria for participants of the clinical study include
patients receiving pressure or volume assist control ventilation who
require ET tube suctioning more frequently than every 2.5 hours.
Patients will be randomized to receive standard closed suctioning or
CleanSweep Closed Suction System. Prior to suctioning, and within 15
minutes thereafter, respiratory system mechanics, hemodynamics, and gas
exchange will be measured. For all participants, data will be collected
from both devices to determine any statistically significant differences
between CleanSweep Closed Suction System and standard closed suction
technique.

"Evaluating the effectiveness of closed suction devices further supports
Teleflex's commitment to developing technologies that help to advance
respiratory care," said Michael DiGiuseppe, Vice President of Teleflex
Respiratory. "CleanSweep Closed Suction System has the potential to make
a positive impact to airway management of the critical care patient."

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to
improve the health and quality of people's lives. We apply
purpose-driven innovation – a relentless pursuit of identifying unmet
clinical needs – to benefit patients and healthcare providers. Our
portfolio is diverse, with solutions in the fields of vascular and
interventional access, surgical, anesthesia, cardiac care, urology,
emergency medicine and respiratory care. Teleflex employees worldwide
are united in the understanding that what we do every day makes a
difference. For more information, please visit teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®,
Rüsch® and Weck® – trusted brands united by a common sense of purpose.

Forward-Looking Statements

Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.

Teleflex, the Teleflex logo, and CleanSweep are trademarks or
registered trademarks of Teleflex Incorporated or its affiliates, in the
U.S. and/or other countries.

© 2018 Teleflex Incorporated.
All rights reserved. MC-004516

View Comments and Join the Discussion!